283 related articles for article (PubMed ID: 35791621)
21. Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States.
Thrasher JR; Arrieta A; Niu F; Cameron KR; Cordero TL; Shin J; Rhinehart AS; Vigersky RA
Diabetes Technol Ther; 2024 Mar; 26(S3):24-31. PubMed ID: 38377317
[No Abstract] [Full Text] [Related]
22. MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life Experience.
Rachmiel M; Lebenthal Y; Mazor-Aronovitch K; Brener A; Levek N; Jacobi-Polishook T; Ben Ari T; Abiri S; Landau Z; Pinhas-Hamiel O
Diabetes Technol Ther; 2023 Sep; 25(9):643-651. PubMed ID: 37219952
[No Abstract] [Full Text] [Related]
23. Switching to an advanced hybrid closed-loop system in real-world practice improves hypoglycemia awareness and metabolic control in adults with type 1 diabetes, particularly in those with impaired perception of hypoglycemia symptoms.
Nattero-Chávez L; Lecumberri Pascual E; De La Calle E; Bayona Cebada A; Ruiz T; Quintero Tobar A; Lorenzo M; Sánchez C; Izquierdo A; Luque-Ramírez M; Escobar-Morreale HF
Diabetes Res Clin Pract; 2023 May; 199():110627. PubMed ID: 36940793
[TBL] [Abstract][Full Text] [Related]
24. Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study.
Seget S; Jarosz-Chobot P; Ochab A; Polanska J; Rusak E; Witoszek P; Chobot A
Front Endocrinol (Lausanne); 2022; 13():1036808. PubMed ID: 36303875
[TBL] [Abstract][Full Text] [Related]
25. Amelioration of user experiences and glycaemic outcomes with an Advanced Hybrid Closed Loop System in a real-world clinical setting.
Beato-Víbora PI; Gallego-Gamero F; Ambrojo-López A; Gil-Poch E; Martín-Romo I; Arroyo-Díez FJ
Diabetes Res Clin Pract; 2021 Aug; 178():108986. PubMed ID: 34329691
[TBL] [Abstract][Full Text] [Related]
26. A Comparison of Two Hybrid Closed-Loop Systems in Italian Children and Adults With Type 1 Diabetes.
Bassi M; Teliti M; Lezzi M; Iosca A; Strati MF; Carmisciano L; d'Annunzio G; Minuto N; Maggi D
Front Endocrinol (Lausanne); 2021; 12():802419. PubMed ID: 35116007
[TBL] [Abstract][Full Text] [Related]
27. Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System.
Kesavadev J; Basanth A; Krishnan G; Shankar A; Sanal G; Jothydev S
Diabetes Ther; 2023 Aug; 14(8):1319-1330. PubMed ID: 37278948
[TBL] [Abstract][Full Text] [Related]
28. Transitioning of People With Type 1 Diabetes From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to MiniMed 780G Advanced Hybrid Closed-Loop System: A Two-Center, Randomized, Controlled Study.
Matejko B; Juza A; Kieć-Wilk B; Cyranka K; Krzyżowska S; Chen X; Cohen O; Da Silva J; Malecki MT; Klupa T
Diabetes Care; 2022 Nov; 45(11):2628-2635. PubMed ID: 35972259
[TBL] [Abstract][Full Text] [Related]
29. Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy.
Lepore G; Borella ND; Castagna G; Ippolito S; Bonfadini S; Corsi A; Scaranna C; Dodesini AR; Bellante R; Trevisan R
Diabetes Technol Ther; 2024 Jan; 26(1):49-58. PubMed ID: 37902785
[No Abstract] [Full Text] [Related]
30. The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system.
Castañeda J; Arrieta A; van den Heuvel T; Cohen O
Diabetes Obes Metab; 2023 Sep; 25(9):2545-2552. PubMed ID: 37246797
[TBL] [Abstract][Full Text] [Related]
31. MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control.
Lombardo F; Passanisi S; Alibrandi A; Bombaci B; Bonfanti R; Delvecchio M; Di Candia F; Mozzillo E; Piccinno E; Piona CA; Rigamonti A; Scialabba F; Maffeis C; Salzano G
Diabetes Technol Ther; 2023 Jun; 25(6):404-413. PubMed ID: 36763343
[No Abstract] [Full Text] [Related]
32. Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
de Portu S; Vorrink L; Re R; Shin J; Castaneda J; Habteab A; Cohen O
BMJ Open; 2022 Feb; 12(2):e050635. PubMed ID: 35110310
[TBL] [Abstract][Full Text] [Related]
33. Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States.
Arunachalum S; Velado K; Vigersky RA; Cordero TL
J Diabetes Sci Technol; 2023 Jul; 17(4):951-958. PubMed ID: 35414272
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two advanced hybrid closed loop in a pediatric population with type 1 diabetes: a real-life observational study.
Schiaffini R; Deodati A; Nicoletti MC; Carducci C; Ciampalini P; Lorubbio A; Matteoli MC; Pampanini V; Patera IP; Rapini N; Cianfarani S
Acta Diabetol; 2022 Jul; 59(7):959-964. PubMed ID: 35451679
[TBL] [Abstract][Full Text] [Related]
35. Long-term effectiveness of advanced hybrid closed loop in children and adolescents with type 1 diabetes.
Piccini B; Pessina B; Casalini E; Lenzi L; Toni S
Pediatr Diabetes; 2022 Dec; 23(8):1647-1655. PubMed ID: 36317539
[TBL] [Abstract][Full Text] [Related]
36. Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch.
Stone MP; Agrawal P; Chen X; Liu M; Shin J; Cordero TL; Kaufman FR
Diabetes Technol Ther; 2018 Oct; 20(10):689-692. PubMed ID: 30160523
[TBL] [Abstract][Full Text] [Related]
37. The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan.
Al-Sofiani ME; Petrovski G; Al Shaikh A; Alguwaihes A; Al Harbi M; Al Mohannadi D; Adjene A; Alagha A; Al Remeithi S; Alamuddin N; Arrieta A; Castañeda J; Chaar W; van den Heuvel T; Cohen O
Diabetes Obes Metab; 2024 Mar; 26(3):937-949. PubMed ID: 38151748
[TBL] [Abstract][Full Text] [Related]
38. Cost-Effectiveness Analysis of an Advanced Hybrid Closed-Loop Insulin Delivery System in People with Type 1 Diabetes in Greece.
Lambadiari V; Ozdemir Saltik AZ; de Portu S; Buompensiere MI; Kountouri A; Korakas E; Sharland H; Cohen O
Diabetes Technol Ther; 2022 May; 24(5):316-323. PubMed ID: 34962140
[No Abstract] [Full Text] [Related]
39. Feasibility Study of a Hybrid Closed-Loop System with Automated Insulin Correction Boluses.
Nimri R; Grosman B; Roy A; Nir J; Fisch Shvalb N; Kurtz N; Loewenthal N; Gillon-Keren M; Muller I; Atlas E; Phillip M
Diabetes Technol Ther; 2021 Apr; 23(4):268-276. PubMed ID: 33185480
[No Abstract] [Full Text] [Related]
40. MiniMed 780GTM in children with type 1 diabetes under seven years of age: Prospective open-label, single-arm, double-center, follow-up study.
Seget S; Chobot A; Rusak E; Ochab A; Bielawska A; Polanska J; Jarosz-Chobot P
Technol Health Care; 2024; 32(3):1463-1472. PubMed ID: 37781828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
